An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD
Enrolling by invitation
Conditions studied: Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD)
In brief
The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once treatment has been initiated.
Key facts
- Study ID
- NCT07217977
- Run by
- Qbtech AB
- People needed
- 175
- Starts
- 2025-01-15
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-05-06
Who can join
Age: 6 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide written informed consent (including parent/legal guardians consent when this is required for individuals under 18 years old and assent as is required based on the age of participant) for QbMobile;
- Aged > 6 years and < 60 years old;
- Referred for an ADHD assessment or has a diagnosis of ADHD but not currently receiving any type of stimulant or nonstimulant medication treatment;
- Meets DSM-5 or ICD-11 criteria for a primary diagnosis of ADHD (combined, inattentive, or hyperactivity/impulsive presentation) per sites standard clinical care evaluation;
- Qbtech Rating Scale total score of >24 at Visit 1;
- Have adequate sensory and physical ability to complete QbMobile;
- Possess or has access to an iPhone model that supports QbMobile.
You may not qualify if…
- Intellectual disability designated by IQ<75);
- Has used psychostimulant medication within 7 days prior to Visit 1;
- A concurrent medical diagnosis that could significantly affect test performance (brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g., vascular dementia, Alzheimer disease, etc);
- Other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);
- Substance use (e.g., alcohol, drugs) that may affect performance on the day of the test.
Where it is running
- Focus-MD — Mobile, Alabama, United States
- Prodigy Psychiatric Group — San Jose, California, United States
- Bokhari Medical Consortium — Largo, Florida, United States
- CCM Clinical Research Group — Miami, Florida, United States
- Nona Pediatric Center — Orlando, Florida, United States
- Godwin Psychiatry — Goldsboro, North Carolina, United States
- MindWell Urgent Care — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.